InVivo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- InVivo Therapeutics's estimated annual revenue is currently $3.5M per year.
- InVivo Therapeutics's estimated revenue per employee is $318,182
- InVivo Therapeutics's total funding is $116.2M.
Employee Data
- InVivo Therapeutics has 11 Employees.
- InVivo Therapeutics grew their employee count by -31% last year.
InVivo Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Quality Assurance | Reveal Email/Phone |
2 | VP, Head Human Resources | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | President / CEO/Chief Medical Officer | Reveal Email/Phone |
5 | CLO and General Counsel | Reveal Email/Phone |
InVivo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is InVivo Therapeutics?
InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on combining polymers and stem cells to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, and Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals, in Boston.
keywords:N/A
$116.2M
Total Funding
11
Number of Employees
$3.5M
Revenue (est)
-31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
InVivo Therapeutics News
The firm set a sell rating on the biotechnology company's stock. Shares of NVIV opened at $0.23 on Wednesday. InVivo Therapeutics has a fifty-...
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focusing on treating spinal cord injuries. The...
InVivo Therapeutics Holdings Corp. said Thursday it will carry out a 1-for-25 reverse stock split, which is intended to increase the...
InVivo Therapeutics, which specializes in spinal cord injuries, named Richard Toselli, M.D., as its president and chief executive. Toselli, who has been acting CEO since December, was also appointed to the company’s board. Sponsored by Agilent Technologies How would you like to win free bench ...
InVivo Therapeutics (OTC:NVIV) said the 1st acute spinal cord injury patient implanted with its investigational neuro-spinal scaffold has shown some improvement, but that a 2nd patient remains paralyzed below the waist, leading investors to punish the company’s stock price last week. Shares of ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1.8M | 11 | N/A | N/A |
#3 | $2.9M | 11 | 0% | N/A |
#4 | $0.9M | 11 | -45% | $107M |
#5 | $1M | 11 | 10% | N/A |